<p>Select Medical Holdings Co.（紐約證券交易所代碼：SEM - 獲取免費報告）的股票獲得了五家覆蓋該公司的券商一致的 “適度買入” 評級，Marketbeat Ratings 報告稱。一位分析師給予該股票持有評級，四位分析師給予該公司買入評級。在過去一年中，給予該股票評級的券商的平均 12 個月目標價為 26.00 美元。</p>
<p>獲取 <strong>Select Medical</strong> 的提醒：</p>
<p>幾位分析師最近對該公司進行了評論。Benchmark 在 2 月 24 日的研究報告中將 Select Medical 的評級從 “持有” 上調至 “買入”，並設定了 23.00 美元的目標價。瑞穗證券在 4 月 16 日的研究報告中開始覆蓋 Select Medical，給予 “跑贏大盤” 評級，並設定了 25.00 美元的目標價。華爾街禪在 2 月 21 日的報告中將 Select Medical 的評級從 “持有” 上調至 “買入”。最後，加拿大皇家銀行在 5 月 7 日的報告中將 Select Medical 的目標價從 23.00 美元下調至 19.00 美元，並給予 “跑贏大盤” 評級。</p>
<p><strong>查看我們關於 Select Medical 的最新報告</strong></p>
<h2>Select Medical 的內部買賣</h2>
<p>在相關消息中，董事 Parvinderjit S. Khanuja 於 5 月 5 日購買了 21,000 股該公司的股票。該股票的平均購買成本為每股 15.02 美元，總價值為 315,420.00 美元。收購完成後，該董事現在直接持有 65,089 股公司的股票，價值約為 977,636.78 美元。這筆交易使他們的持股增加了 47.63%。該購買在向美國證券交易委員會（SEC）提交的法律文件中披露，相關文件可通過此鏈接訪問。此外，首席執行官 David S. Chernow 於 4 月 28 日的交易中出售了 225,000 股公司的股票。該股票的平均售價為 18.00 美元，總價值為 4,050,000.00 美元。交易完成後，首席執行官現在直接持有 714,516 股公司的股票，價值為 12,861,288 美元。這筆交易使他們的持股減少了 23.95%。該銷售的披露信息可以在這裏找到。11.60% 的股票由公司內部人士持有。</p>
<h2>對 Select Medical 的對沖基金看法</h2>
<p>大型投資者最近對該股票的持倉進行了調整。Smartleaf Asset Management LLC 在第四季度將其在 Select Medical 的持股增加了 179.0%。Smartleaf Asset Management LLC 現在擁有 2,296 股該健康服務提供商的股票，價值 43,000 美元，此前在該期間內又收購了 1,473 股。凱通國際資產管理有限公司在第一季度將其在 Select Medical 的持股增加了 61.6%。凱通國際資產管理有限公司現在擁有 2,703 股該健康服務提供商的股票，價值 45,000 美元，此前在該期間內又收購了 1,030 股。BI Asset Management Fondsmaeglerselskab A S 在第一季度購買了 Select Medical 的新頭寸，價值 60,000 美元。Covestor Ltd 在第四季度將其在 Select Medical 的持股增加了 33.5%。Covestor Ltd 現在擁有 4,955 股該健康服務提供商的股票，價值 93,000 美元，此前在該期間內又收購了 1,244 股。最後，Advisors Asset Management Inc. 在第一季度將其在 Select Medical 的持股增加了 168.2%。Advisors Asset Management Inc. 現在擁有 6,301 股該健康服務提供商的股票，價值 105,000 美元，此前在該期間內又收購了 3,952 股。89.48% 的股票由機構投資者持有。</p>
<h2>Select Medical 股票下跌 0.3%</h2>
<p>SEM 股票在週四開盤價為 15.26 美元。該股票的 50 日簡單移動平均線為 15.84 美元，200 日簡單移動平均線為 18.61 美元。Select Medical 的 52 周低點為 14.03 美元，52 周高點為 40.98 美元。該公司的債務與股本比率為 1.37，速動比率為 1.13，流動比率為 1.13。該公司的市值為 19.6 億美元，市盈率為 9.25，市盈增長比率為 0.64，貝塔值為 1.40。</p>
<p>Select Medical（紐約證券交易所代碼：SEM - 獲取免費報告）最近於 5 月 1 日發佈了季度財報。該健康服務提供商報告本季度每股收益為 0.44 美元，低於市場共識預期的 0.45 美元（差額為 0.01 美元）。該公司本季度的收入為 13.5 億美元，而分析師預期為 14.0 億美元。Select Medical 的股本回報率為 14.04%，淨利潤率為 3.23%。該公司的季度收入較去年同期下降了 24.4%。去年同期，該公司每股收益為 0.75 美元。研究分析師平均預計 Select Medical 在當前財政年度的每股收益為 1.17 美元。</p>
<p>Select Medical 宣佈其董事會已於 5 月 1 日授權一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許該健康服務提供商通過公開市場購買最多 42.6% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>Select Medical 宣佈分紅</h2>
<p>該公司還最近披露了一項季度分紅，該分紅於 5 月 29 日支付。5 月 15 日的股東獲得每股 0.0625 美元的分紅。這代表着每年 0.25 美元的分紅和 1.64% 的收益率。該分紅的除息日期為 5 月 15 日。Select Medical 的分紅支付比率（DPR）為 18.66%。</p>
<h2>Select Medical 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>選擇醫療控股公司通過其子公司在美國運營重症恢復醫院、康復醫院、門診康復診所和職業健康中心。它分為四個業務部門：重症恢復醫院、康復醫院、門診康復和 Concentra。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比選擇醫療更好的股票</li>
<li>消費者非必需品股票解析</li>
<li>Intuit 的人工智能熱潮：股票飆升，但投資者應該暫停嗎？</li>
<li>低市盈率成長股：解鎖投資機會</li>
<li>強分析師評級的頂級分紅股票</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克將何時關閉</li>
<li>Robinhood 股票持續給投資者提供購買理由</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在選擇醫療嗎？</h2>
<p>在考慮選擇醫療之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而選擇醫療並不在名單上。</p>
<p>雖然選擇醫療目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Select醫藥控股

<p>Select Medical Holdings Co.（紐約證券交易所代碼：SEM）獲得了五家券商的 “適度買入” 共識評級。一位分析師將其評級為持有，四位分析師將其評級為買入，12 個月的平均目標價為 26.00 美元。最近的分析師行動包括 Benchmark 將其評級上調至買入，目標價為 23.00 美元，以及瑞穗開始覆蓋，目標價為 25.00 美元。內部交易方面，一位董事購買了 21,000 股，而首席執行官出售了 225,000 股。該股票目前下跌 0.3%，交易價格為 15.26 美元，市值為 19.6 億美元</p>

<p>Shares of Select Medical Holdings Co. (NYSE:SEM - Get Free Report) have received a consensus rating of &#34;Moderate Buy&#34; from the five brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $26.00.</p>
<div class="lb-trans"><p>Select Medical Holdings Co.（紐約證券交易所代碼：SEM - 獲取免費報告）的股票獲得了五家覆蓋該公司的券商一致的 “適度買入” 評級，Marketbeat Ratings 報告稱。一位分析師給予該股票持有評級，四位分析師給予該公司買入評級。在過去一年中，給予該股票評級的券商的平均 12 個月目標價為 26.00 美元。</p>
</div><p>Get <strong>Select Medical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Select Medical</strong> 的提醒：</p>
</div><p>Several analysts have recently commented on the company. Benchmark raised Select Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $23.00 price objective for the company in a research note on Monday, February 24th. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an &#34;outperform&#34; rating and a $25.00 price objective for the company. Wall Street Zen raised Select Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Friday, February 21st. Finally, Royal Bank of Canada reduced their target price on Select Medical from $23.00 to $19.00 and set an &#34;outperform&#34; rating for the company in a report on Wednesday, May 7th.</p>
<div class="lb-trans"><p>幾位分析師最近對該公司進行了評論。Benchmark 在 2 月 24 日的研究報告中將 Select Medical 的評級從 “持有” 上調至 “買入”，並設定了 23.00 美元的目標價。瑞穗證券在 4 月 16 日的研究報告中開始覆蓋 Select Medical，給予 “跑贏大盤” 評級，並設定了 25.00 美元的目標價。華爾街禪在 2 月 21 日的報告中將 Select Medical 的評級從 “持有” 上調至 “買入”。最後，加拿大皇家銀行在 5 月 7 日的報告中將 Select Medical 的目標價從 23.00 美元下調至 19.00 美元，並給予 “跑贏大盤” 評級。</p>
</div><p><strong>Check Out Our Latest Report on Select Medical</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Select Medical 的最新報告</strong></p>
</div><h2>Insider Buying and Selling at Select Medical</h2>
<div class="lb-trans"><h2>Select Medical 的內部買賣</h2>
</div><p>In related news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the business's stock in a transaction dated Monday, May 5th. The stock was purchased at an average cost of $15.02 per share, with a total value of $315,420.00. Following the completion of the acquisition, the director now directly owns 65,089 shares of the company's stock, valued at approximately $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at $12,861,288. The trade was a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，董事 Parvinderjit S. Khanuja 於 5 月 5 日購買了 21,000 股該公司的股票。該股票的平均購買成本為每股 15.02 美元，總價值為 315,420.00 美元。收購完成後，該董事現在直接持有 65,089 股公司的股票，價值約為 977,636.78 美元。這筆交易使他們的持股增加了 47.63%。該購買在向美國證券交易委員會（SEC）提交的法律文件中披露，相關文件可通過此鏈接訪問。此外，首席執行官 David S. Chernow 於 4 月 28 日的交易中出售了 225,000 股公司的股票。該股票的平均售價為 18.00 美元，總價值為 4,050,000.00 美元。交易完成後，首席執行官現在直接持有 714,516 股公司的股票，價值為 12,861,288 美元。這筆交易使他們的持股減少了 23.95%。該銷售的披露信息可以在這裏找到。11.60% 的股票由公司內部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Select Medical</h2>
<div class="lb-trans"><h2>對 Select Medical 的對沖基金看法</h2>
</div><p>Large investors have recently made changes to their positions in the stock. Smartleaf Asset Management LLC boosted its holdings in shares of Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Select Medical by 61.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after acquiring an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Select Medical in the first quarter worth $60,000. Covestor Ltd boosted its holdings in shares of Select Medical by 33.5% in the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares during the period. Finally, Advisors Asset Management Inc. boosted its holdings in shares of Select Medical by 168.2% in the first quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider's stock worth $105,000 after acquiring an additional 3,952 shares during the period. 89.48% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>大型投資者最近對該股票的持倉進行了調整。Smartleaf Asset Management LLC 在第四季度將其在 Select Medical 的持股增加了 179.0%。Smartleaf Asset Management LLC 現在擁有 2,296 股該健康服務提供商的股票，價值 43,000 美元，此前在該期間內又收購了 1,473 股。凱通國際資產管理有限公司在第一季度將其在 Select Medical 的持股增加了 61.6%。凱通國際資產管理有限公司現在擁有 2,703 股該健康服務提供商的股票，價值 45,000 美元，此前在該期間內又收購了 1,030 股。BI Asset Management Fondsmaeglerselskab A S 在第一季度購買了 Select Medical 的新頭寸，價值 60,000 美元。Covestor Ltd 在第四季度將其在 Select Medical 的持股增加了 33.5%。Covestor Ltd 現在擁有 4,955 股該健康服務提供商的股票，價值 93,000 美元，此前在該期間內又收購了 1,244 股。最後，Advisors Asset Management Inc. 在第一季度將其在 Select Medical 的持股增加了 168.2%。Advisors Asset Management Inc. 現在擁有 6,301 股該健康服務提供商的股票，價值 105,000 美元，此前在該期間內又收購了 3,952 股。89.48% 的股票由機構投資者持有。</p>
</div><h2>Select Medical Stock Down 0.3%</h2>
<div class="lb-trans"><h2>Select Medical 股票下跌 0.3%</h2>
</div><p>SEM stock opened at $15.26 on Thursday. The stock's 50 day simple moving average is $15.84 and its 200 day simple moving average is $18.61. Select Medical has a fifty-two week low of $14.03 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $1.96 billion, a P/E ratio of 9.25, a price-to-earnings-growth ratio of 0.64 and a beta of 1.40.</p>
<div class="lb-trans"><p>SEM 股票在週四開盤價為 15.26 美元。該股票的 50 日簡單移動平均線為 15.84 美元，200 日簡單移動平均線為 18.61 美元。Select Medical 的 52 周低點為 14.03 美元，52 周高點為 40.98 美元。該公司的債務與股本比率為 1.37，速動比率為 1.13，流動比率為 1.13。該公司的市值為 19.6 億美元，市盈率為 9.25，市盈增長比率為 0.64，貝塔值為 1.40。</p>
</div><p>Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business's revenue for the quarter was down 24.4% compared to the same quarter last year. During the same period last year, the company earned $0.75 earnings per share. On average, research analysts expect that Select Medical will post 1.17 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Select Medical（紐約證券交易所代碼：SEM - 獲取免費報告）最近於 5 月 1 日發佈了季度財報。該健康服務提供商報告本季度每股收益為 0.44 美元，低於市場共識預期的 0.45 美元（差額為 0.01 美元）。該公司本季度的收入為 13.5 億美元，而分析師預期為 14.0 億美元。Select Medical 的股本回報率為 14.04%，淨利潤率為 3.23%。該公司的季度收入較去年同期下降了 24.4%。去年同期，該公司每股收益為 0.75 美元。研究分析師平均預計 Select Medical 在當前財政年度的每股收益為 1.17 美元。</p>
</div><p>Select Medical declared that its Board of Directors has authorized a stock repurchase plan on Thursday, May 1st that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Select Medical 宣佈其董事會已於 5 月 1 日授權一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許該健康服務提供商通過公開市場購買最多 42.6% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Select Medical Announces Dividend</h2>
<div class="lb-trans"><h2>Select Medical 宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend was Thursday, May 15th. Select Medical's dividend payout ratio (DPR) is 18.66%.</p>
<div class="lb-trans"><p>該公司還最近披露了一項季度分紅，該分紅於 5 月 29 日支付。5 月 15 日的股東獲得每股 0.0625 美元的分紅。這代表着每年 0.25 美元的分紅和 1.64% 的收益率。該分紅的除息日期為 5 月 15 日。Select Medical 的分紅支付比率（DPR）為 18.66%。</p>
</div><h2>Select Medical Company Profile</h2>
<div class="lb-trans"><h2>Select Medical 公司簡介</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.</p>
<div class="lb-trans"><p>選擇醫療控股公司通過其子公司在美國運營重症恢復醫院、康復醫院、門診康復診所和職業健康中心。它分為四個業務部門：重症恢復醫院、康復醫院、門診康復和 Concentra。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Select Medical</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Intuit's AI Boom: Stock Soaring, But Should Investors Hit Pause?</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Top Dividend Plays With Strong Analyst Ratings</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Robinhood Stock Keeps Giving Investors Reasons To Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比選擇醫療更好的股票</li>
<li>消費者非必需品股票解析</li>
<li>Intuit 的人工智能熱潮：股票飆升，但投資者應該暫停嗎？</li>
<li>低市盈率成長股：解鎖投資機會</li>
<li>強分析師評級的頂級分紅股票</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克將何時關閉</li>
<li>Robinhood 股票持續給投資者提供購買理由</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=SEM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Select Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在選擇醫療嗎？</h2>
</div><p>Before you consider Select Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮選擇醫療之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而選擇醫療並不在名單上。</p>
</div><p>While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然選擇醫療目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

分析師一致推薦 Select Medical Holdings Co.（紐約證券交易所代碼：SEM）為 “適度買入”